Julphar Withdraws Cefuzime

Julphar has taken the decision to withdraw certain batches of Cefuzime 250mg and 500mg tablets due to an issue over the product's stability. We take this issue very seriously and are working closely with the relevant Health Authorities.
As per GMP requirements, it is our duty to ensure that every product we manufacture is safe and of the highest quality. That means we must cooperate fully with each and every Health Authorities to identify any problem and ensure we get everything right. We ask that you bear with us during this time as we work to rectify the situation. When more information is available we will be providing updates through our website and our social media channels.
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.